-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
on June 26,, Hebang Issued:evTJune 25th, according to the preparation of the project, Sichuan and Bang Share Branch Co., Ltd50,000 tons /year methionine project officially started constructionevT
The total investment of the 50,000 tons/year methionine project is RMB 129,57 million, of which RMB120,897 million is invested in construction and RMB 86.72 million in working capitalConstruction cycle: 2.25 yearsevT
The project is the company's 2014 non-public offering of shares, is an extension of the company's existing industrial chain, in line with the relevant national industrial policy and the future of the company to food and pharmaceutical nutrition agents, agricultural e-commerce, new materials overall strategic development direction, with good prospects for development and economic benefitsThe successful implementation of the project can further expand the company's industrial chain layout, enrich the product structure and promote product diversification, increase the company's working capital, optimize the financial structure, improve the ability to resist risks, enhance the company's sustainable profitabilityevTJune 26, and Bang shares issued a notice:evTJune 25, according to the preparation of the project, Sichuan and Bang Share Branch Co., Ltd 50,000 tons / year methionine project officially started construction evT
The total investment of the 50,000 tons/year methionine project is RMB 129,57 million, of which RMB120,897 million is invested in construction and RMB 86.72 million in working capital Construction cycle: 2.25 years evT
The project is the company's 2014 non-public offering of shares, is an extension of the company's existing industrial chain, in line with the relevant national industrial policy and the future of the company to food and pharmaceutical nutrition agents, agricultural e-commerce, new materials overall strategic development direction, with good prospects for development and economic benefits The successful implementation of the project can further expand the company's industrial chain layout, enrich the product structure and promote product diversification, increase the company's working capital, optimize the financial structure, improve the ability to resist risks, enhance the company's sustainable profitability evT
Share it on feed